CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 229 filers reported holding CONMED CORP in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $292 | +113.1% | 4,220 | +145.1% | 0.00% | – |
Q1 2024 | $137 | -35.1% | 1,722 | -15.3% | 0.00% | – |
Q1 2023 | $211 | +205.8% | 2,033 | +158.7% | 0.00% | – |
Q4 2022 | $69 | -99.9% | 786 | 0.0% | 0.00% | – |
Q3 2022 | $63,000 | -16.0% | 786 | 0.0% | 0.00% | – |
Q2 2022 | $75,000 | -98.9% | 786 | -98.3% | 0.00% | -100.0% |
Q1 2022 | $6,925,000 | -14.0% | 46,620 | -17.9% | 0.01% | -11.1% |
Q4 2021 | $8,052,000 | +17031.9% | 56,802 | +15634.6% | 0.01% | – |
Q3 2021 | $47,000 | -89.7% | 361 | -89.6% | 0.00% | -100.0% |
Q1 2021 | $455,000 | -49.1% | 3,485 | -56.4% | 0.00% | 0.0% |
Q4 2020 | $894,000 | +3338.5% | 7,991 | +2299.7% | 0.00% | – |
Q3 2020 | $26,000 | -40.9% | 333 | -45.9% | 0.00% | – |
Q2 2020 | $44,000 | -96.4% | 615 | -97.2% | 0.00% | -100.0% |
Q1 2020 | $1,238,000 | +33.8% | 21,630 | +161.2% | 0.00% | +100.0% |
Q4 2019 | $925,000 | +44.5% | 8,280 | +24.2% | 0.00% | 0.0% |
Q3 2019 | $640,000 | +63.3% | 6,665 | +45.2% | 0.00% | 0.0% |
Q2 2019 | $392,000 | – | 4,591 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |